Evidence map›Paper›PMID 38482214›Full record

ArticleJournal of gastrointestinal oncology2024

Postoperative superior anastomotic leakage classification and treatment strategy for postoperative esophagogastric junction cancer.

Junli Zhang, Changzheng Li, Pengfei Ma, Yanghui Cao, Janusz Włodarczyk, Mohsen Ibrahim, Chenyu Liu, Sen Li, Xijie Zhang, Guangsen Han and 1 more

Abstract read
In one paragraph

Article in Journal of gastrointestinal oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Junli ZhangDepartment of General Surgery, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Changzheng LiDepartment of General Surgery, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Pengfei MaDepartment of General Surgery, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Yanghui CaoDepartment of General Surgery, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Janusz WłodarczykDepartment of Thoracic and Surgical Oncology, Jagiellonian University Medical College, John Paul II Hospital, Cracow, Poland.
Mohsen IbrahimDivision of Thoracic Surgery, Department of Medical and Surgical Sciences and Translational Medicine, Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy.
Chenyu LiuDepartment of General Surgery, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Sen LiDepartment of General Surgery, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Xijie ZhangDepartment of General Surgery, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Guangsen HanDepartment of General Surgery, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Yuzhou ZhaoDepartment of General Surgery, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: At present, anastomotic fistula cannot be avoided after adenocarcinoma of the esophagogastric junction (AEG). Once the anastomotic leakage occurs, the posterior mediastinum and the left thoracic cavity are often seriously infected, which further impairs respiratory and circulatory function, heightening the danger of the disease course. The aim of this study was to identify the characteristics of superior anastomotic leakage after surgery for AEG and recommend corresponding treatment strategies to improve the diagnosis and treatment of superior anastomotic leakage after surgery for AEG. Methods: The clinical data of 57 patients with superior anastomotic leakage after surgery for AEG in the Affiliated Cancer Hospital of Zhengzhou University from January 2017 to March 2019 were retrospectively analyzed, including 27 cases referred from external hospitals and 30 cases at the Affiliated Cancer Hospital of Zhengzhou University. According to the diameter and risk level of anastomotic leakage, the high anastomotic leakage is divided into types I, II, III, and IV. Results: Patients with preoperative comorbidities or those treated with the transabdominal approach or laparoscopic surgery often had type I and type II anastomotic leakage; meanwhile, patients with preoperative comorbidities and sacral perforation or those treated with a thoracic and abdominal approach or open surgery often had type III and IV fistula. The difference between types I-II and types III-IV was statistically significant (P<0.05). The mortality rate of patients with type III and type IV leakage was 14.8% within 90 days after operation, while no deaths occurred among patients with type I and type II leakage, and the difference in mortality between the two groups was statistically significant (P<0.05). Conclusions: After surgery for AEG, suitable treatment measures should be adopted according to the type of superior anastomotic leakage that occurs. Types III and IV superior anastomotic leakages are associated with higher mortality and require greater attention from surgeons.

Indexed as

classificationEsophagogastric junction cancer (EGJ cancer)superior anastomotic leakagetreatment

Identifiers

PMID38482214
PMCPMC10932668

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.